Invention Grant
US08435492B2 Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
有权
在放射性药物的合成中与锡基聚合物连接的假体组
- Patent Title: Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
- Patent Title (中): 在放射性药物的合成中与锡基聚合物连接的假体组
-
Application No.: US10555248Application Date: 2004-04-30
-
Publication No.: US08435492B2Publication Date: 2013-05-07
- Inventor: Duncan Hunter , M. Karen J. Gagnon
- Applicant: Duncan Hunter , M. Karen J. Gagnon
- Applicant Address: CA London, Ontario
- Assignee: University of Western Ontario
- Current Assignee: University of Western Ontario
- Current Assignee Address: CA London, Ontario
- Agency: K&L Gates LLP
- Agent John M. Garvey; Pei Wu
- International Application: PCT/IB2004/001834 WO 20040430
- International Announcement: WO2004/098650 WO 20041118
- Main IPC: A61K51/00
- IPC: A61K51/00

Abstract:
The present invention relates to compositions and methods for preparing radiopharmaceutical compounds in high chemical-purity and isotopic-purity. The present invention provides polymer-bound precursors to radiopharmaceutical compounds that can be converted to radiopharmaceutical compounds in one step. In a preferred embodiment, a radiopharmaceutical precursor is bound to a polymeric support via a prosthetic group comprising an alkenyl-tin bond. The radiopharmaceutical precursor is converted to a radiopharmaceutical compound in one step involving cleavage of the alkenyl-tin bond and incorporation of a radioisotope to form the radiopharmaceutical compound. Importantly, the polymeric support containing the toxic tin by-product can be easily removed from the radiopharmaceutical compound by filtration. The present invention can be used to install a large number of different radioisotopes. In a preferred embodiment, the radioisotope is 211At, 123I or 131I.
Public/Granted literature
- US20070155976A1 Prosthetic groups useful in the synthesis of radiopharmaceutical compounds Public/Granted day:2007-07-05
Information query